Nuclear quality control and DNA damage
Joanna Loizou completed her undergraduate studies and PhD in the UK. Postdoctoral work followed at the IARC, WHO, France and the London Research Institute, Cancer Research UK. Joanna established her independent group in 2011 in Vienna at CeMM/Medical University of Vienna.
- Institute CeMM - Research Center for Molecular Medicine
- Phone +43 1 40160 70058
- Mail JLoizou@cemm.oeaw.ac.at
Projects within consortium
The human genome is constantly exposed to endogenous and exogenous sources of DNA damage. DNA repair ensures the integrity of large eukaryotic genomes by minimising the mutation rate. Several highly effective pathways for DNA repair with distinct specificities exist, which are evolutionary conserved despite partial redundancies. Our lab investigates how cellular decisions are made to engage one repair pathway over another and the molecular mechanisms that lead to DNA repair.
Helix distorting DNA damage, that is encountered by RNAPII, is mostly repaired by transcription-coupled nucleotide excision repair (TC-NER). When TC-NER cannot allow for continued transcription, the stalled RNAPII is removed to allow for access by DNA repair proteins that function to repair the DNA lesion. Removal is thought to be achieved by poly-ubiquitination and degradation of RPB1, the largest subunit of RNAPII. Hence, degradation of RPB1 following DNA damage functions to regulate two fundamental cellular process: DNA repair and transcription.
Our overall goal is to understand how the UPS interacts with RNAPII to clear stalled transcription complexes from sites of DNA damage, in human cells. Firstly, we will identify genetic factors required for (de)stabilization of RPB1. To do so we will use a focused sgRNA CRISPR library targeting E3 proteins, deubiquitylating (DUB) enzymes, and accessory proteins (that function within this pathway), hence identifing which proteins (de)stabilize RPB1. Secondly, we will identify potential E3 ligases and DUB enzymes that add or remove poly-ubiquitin from RPB1, taking orthogonal proteomics-based approaches. Finally, we will investigate the mechanisms by which the identified E3s and DUBs affect RPB1 degradation and stabilization, as well as the subsequent cellular outcomes. Here, we will map the type and position of ubiquitylation mediated by the identified E3 and removed by the DUB. We will determine the impact of ubiquitylation/deubiquitylation of RPB1 on DNA repair and transcription.
Taken together, this multidisciplinary proposal will clarify mechanisms and outcomes of RNAPII degradation following DNA damage, in order to coordinate transcription and DNA repair.
Targeted Protein Degradation related publications by Group Loizou
- 2021 Decomposing the mutational landscape of cancer genomes with RepairSig Cell Systems Go to publication →
- 2018 Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48 Nat. Commun. Go to publication →
- 2017 Repair of UV-Induced DNA Damage Independent of Nucleotide Excision Repair Is Masked by MUTYH Mol. Cell Go to publication →
- 2017 Parallel genome-wide screens identify a synthetic viable interaction between the BLM helicase complex and Fanconi anemia Nat. Commun. Go to publication →